MPX International Corp MPXOF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- $0.00 / $0.01
- Market Cap
- $288,645.11
- Volume/Avg
- 36,575 / 2,760
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
MPX International Corp is a diversified cannabis company focused on developing and operating assets across the global medical and adult use and engaged in cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient. The firm is organized into three segments: Canada, Europe/Africa, and Asia-Pacific. The Canada operating segment's principal business activities consist of production and sale of cannabis, video learning and engagement, patient counselling and referral services. The Europe/Africa operating segment's consist of the production and sale of cannabis and hemp-related products. The Asia-Pacific consist of the production and sale of cannabis. The majority of the revenue is generated in Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- —
Valuation
|
Metric
|
MPXOF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
MPXOF
|
|---|---|
Quick Ratio | 0.15 |
Current Ratio | 0.47 |
Interest Coverage | −2.45 |
Quick Ratio
MPXOF
Profitability
|
Metric
|
MPXOF
|
|---|---|
Return on Assets (Normalized) | −48.08% |
Return on Equity (Normalized) | −458.70% |
Return on Invested Capital (Normalized) | −44.89% |
Return on Assets
MPXOF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Ddtxfkfgzs | Xvp | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Zqpxxfvx | Qwcjyr | $70.8 Bil | |
HLN
| Haleon PLC ADR | Wrmwgbw | Gfyg | $38.2 Bil | |
VTRS
| Viatris Inc | Pyzbdypc | Tpms | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Tkcttbkgf | Tvm | $12.5 Bil | |
CTLT
| Catalent Inc | Kdgsmdf | Rgqbnfz | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Szjtmxp | Wqymd | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Mmbhgpwh | Vsglt | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vrmkydt | Jzgvlcb | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Nrpngllhfl | Cwbv | $2.9 Bil |